sulatum in vitro [7] . City, Missouri 64108 (dbamberger@pop.umkc.edu). Itraconazole is more active than ketoconazole or fluconazole in Clinical Infectious Diseases 1999;28:915-6 non-CNS histoplasmosis [7, 8]. In animal models, concentrations Service, Hospital de Bellvitge, 08907 L'Hospitalet de Llobregat, Barcelona, nii. Intraventricular colistimethate sodium (5 mg/12 h), given Spain.
Successful Treatment of Multiple Cerebral Histoplasmomas with Itraconazole
Amphotericin B has been suggested as the treatment of choice for cerebral histoplasmomas, but it is effective in only about half of cases [1] . In the review by Wheat et al. [1] , no cases of cerebral histoplasmomas resolved without antifungal therapy, and only two were treated with azoles. I am unaware of previous reports of itraconazole use for CNS histoplasmosis.
A 53-year-old woman with a history of type II diabetes mellitus presented with a 3-week history of confusion, dysarthria, rightsided weakness, left-sided eyelid ptosis, weakness of gaze to the right, right-sided hyperreflexia, and left-sided neglect. She denied having chills or sweats and was afebrile.
Four months earlier, she had had a platelet count of 5,000/mm 3 and was treated with corticosteroids and intravenous immunoglobulin for idiopathic immune thrombocytopenia. During that time, she had a brief febrile illness; a bone marrow examination revealed noncaseating granulomas, and a chest radiograph showed increased interstitial markings. Her platelet count, fever, and chest radiograph returned to normal after a few days, and corticosteroid treatment was tapered and then discontinued 3 weeks before her neurological symptoms began. Figure 1 . Post -gadolinium contrast T 1 -weighted axial cerebral At the time of her neurological symptoms, an MRI scan revealed MRI in a 53-year-old patient with cerebral histoplasmomas. numerous lesions (diameter, õ1 cm) of the grey and white matter of the frontal, parietal, and occipital lobes and lesions within the midbrain and brain stem (figure 1). The lesions enhanced after revealed a decrease in the number and size of the lesions and in intravenous injection of gadolinium, and some had surrounding the surrounding edema. She continued to receive itraconazole for edema. An abdominal CT scan showed the left adrenal to be 3. 4 1 year. Another MRI scan done 4 months after discontinuation of 1 3.9 cm with a hypodense center and hyperdense rim. A chest therapy revealed no change from the scan at the end of therapy. radiograph was normal. A fine-needle adrenal aspirate showed More than 2.5 years after discontinuing therapy, the patient renondiagnostic results. On CSF testing, the following values were mains asymptomatic. noted: glucose, 52 mg/dL; protein, 61 mg/dL; RBCs, 0/mm 3 ;
The patient described had evidence of cerebral histoplasmomas, WBCs, 1/mm 3 (100% mononuclear). Bone marrow and CSF culdespite the lack of a brain biopsy. H. capsulatum was found in tures were negative. The Histoplasma capsulatum polysaccharide the adrenal gland, antibodies to H. capsulatum were present in antigen level in serum was 0.5 U and in CSF was 0.7 U. The CSF, and the lesions and symptoms responded to antifungal therpatient was negative for IgG antibodies to Echinococcus species apy. Negative cultures of CSF and a negative result on CSF hisand HIV and IgM antibodies to Toxoplasma species in serum. Her toplasma polysaccharide antigen testing are observed in about half serum was positive for IgG antibodies to Toxoplasma species, but of cases of CNS histoplasmosis [1] . It is likely that her disease the ratio of Toxoplasma IgG antibodies to total IgG was twofold was related to the immunosuppressive effects of the corticostegreater in serum than in CSF. Her titer of complement fixation roids, despite discontinuation of corticosteroids 3 weeks before antibody to H. capsulatum in CSF was 1:2 for the mycelial antigen her neurological symptoms began. and 1:4 for the yeast antigen. An open adrenal biopsy revealed Two cases of cerebral histoplasmomas have been successfully extensive necrosis, granulomatous inflammation, and organisms treated with ketoconazole after relapse following therapy with inconsistent with histoplasmosis. Culture of adrenal tissue yielded travenous amphotericin B [2, 3] . There has also been a report of H. capsulatum.
treatment failure with ketoconazole therapy for cerebral histoplas-The patient refused therapy with amphotericin B. She began momas [4] . Ketoconazole has been associated with treatment failreceiving itraconazole, 200 mg three times daily for 3 days, folures in immunocompromised patients with histoplasmosis and has lowed by 200 mg twice daily. Her neurological signs and symppoor penetration into CSF [1] . Two reported cases of CNS histotoms improved over the next 3 months, and repeat MRI scans plasmosis have been treated with fluconazole, which crosses the blood-brain barrier, but the length of follow-up was short [5, 6] . Fluconazole is associated with treatment failures and relapses in both immunocompetent and immunocompromised patients with increased, and CSF analysis revealed 27,900 cells/mm 3 (95% poly-
Successful Treatment of Ventriculitis Due to
morphonuclear cells), and cultures of CSF yielded A. baumannii.
Carbapenem-Resistant Acinetobacter baumannii with
Meropenem was discontinued, and intraventricular tobramycin (10 Intraventricular Colistin Sulfomethate Sodium mg/12 h), intravenous tobramycin (5 mg/kg once a day), and intravenous sulbactam (2 g/6 h) were then initiated. On day 19, because CSF Over the past 2 decades, Acinetobacter baumannii has develcultures remained positive, the ventriculostomy tube was replaced and oped one of the most alarming patterns of antibiotic resistance intraventricular tobramycin was switched to intraventricular colistiever observed [1] . Nowadays, since an increasing proportion of methate sodium (5 mg/12 h), intravenous tobramycin was maintained, isolates are resistant to all antibiotics tested routinely, therapy is and intravenous sulbactam was discontinued. Intraventricular colistin a serious challenge [2] . Beginning in 1992, a large outbreak due was administered in a 5-mL solution of saline serum through the to multiresistant A. baumannii was noted in our 1,000-bed tertiary ventriculostomy tube after previous extraction of 5 mL of CSF, and teaching hospital, causing considerable imipenem overuse [3] . In thereafter, the drainage was interrupted for 3 hours. On day 21, cul-January 1997, two clones resistant to carbapenems emerged: clone tures of CSF were negative and remained so until colistin sulfometh-D, moderately resistant to imipenem (MICs, 4-16 mg/L) and toate sodium therapy was ended on day 39, when a ventriculoperitoneal bramycin (MIC, 8 mg/L) and susceptible only to sulbactam and shunt was inserted. During therapy, CSF bactericidal titers at 3 hours polymyxins (MICs, £4 mg/L), and clone E, highly resistant to after colistin sulfomethate sodium administration (peak) were 1/2, imipenem and sulbactam (MICs, ú256 mg/L), moderately resisand before doses were administered (trough), titers ranged from tant to tobramycin (MIC, 8 mg/L), and susceptible only to poly-õ1/2 to 1/4. Similarly, CSF bacteriostatic titers at peak were 1/8 and myxins. Since then, five patients have developed catheter-associat trough ranged from 1/4 to 1/16. Levels of tobramycin in CSF varied ated ventriculitis due to carbapenem-resistant A. baumannii strains from 7.9 mg/L (peak) to 0.7 mg/L (trough). No adverse reactions were (table 1). Of these five patients, three died of their infection after documented during therapy. On day 82, the patient was alert with receiving inadequate therapy (patients 1-3) . The other two are, to spontaneous mobilization of the extremities, but he died suddenly of our knowledge, the first reported to date who survived after treatcardiac arrest. Postmortem examination ruled out ventriculitis, and ment with intraventricular colistin sulfomethate sodium (patients cultures of CSF were negative for A. baumannii. 4 and 5).
Patient 5 was a 34-year-old woman who required an external Patient 4 was a 16-year-old boy who underwent surgery and the ventriculostomy tube because of subarachnoid hemorrhage with insertion of an external ventriculostomy tube for continuous drainage hydrocephalus. The catheter was removed 6 days after insertion; because of hemangioblastoma of the fourth ventricle. On day 7 after however, 24 hours later, the patient developed high fever and surgery, meropenem at 2 g/8 h was started empirically to treat his neurological symptoms worsened, with purulent secretion from the fever, although CSF cultures had been sterile. On day 16, his fever catheter insertion site. CSF obtained through a new ventricular drainage site was cloudy, showing 2,000 cells/mm 3 (95% polymorphonuclear cells) and short gram-negative rods on gram stain.
